Literature DB >> 31522588

Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.

Ling Liu1, Xin Yang2, Nian-Feng Li1, Ling Lin1, Hui Luo1.   

Abstract

Background: Hepatocellular carcinoma (HCC) afflicts more than half a million people each year worldwide. It was reported that circ_0015756 was up-regulated in HCC, but the mechanism did not extensively studied.
Methods: we collected 24 paired cancerous and noncancerous liver tissues surgically resected from HCC patients. HCC cell proliferation, invasion, migration and apoptosis in vitro were evaluated using MTT assay, Transwell assay, scratch test and Annexin-V/PI staining respectively. Interactions between circ_0015756 and miR-7, miR-7 and FAK were further validated by the luciferase reporter assay. Tumor xenografts of HCC cells with circ_0015756 knockdown were established in nude mice.
Results: The expression level of circ_0015756 was increased and the expression level of miR-7 was diminished in cancerous liver tissues relative to noncancerous liver tissues. Circ_0015756 knockdown was shown to increase the expression of miR-7, reduce the proliferation, invasion, migration and resistance to apoptosis, and down-regulate the expression of FAK in HCC. We found miR-7 impaired expression of FAK to inhibit HCC cells, suggesting that miR-7 is responsible for the dysfunction of FAK. Importantly, we showed circ_0015756 could up-regulate FAK via targeting miR-7. These in vitro findings were reproduced in vivo that circ_0015756 knockdown decreased HCC xenograft growth.
Conclusion: Our present study reveals a model of HCC development that is composed of circ_0015756, miR-7 and FAK. Modulation of their levels exhibits a promise in the treatment of HCC. Abbreviations: HCC: hepatocellular carcinoma; circRNAs: circular RNAs; miRNA/miR: microRNA; miR-7: microRNA-7; FAK: focal adhesion kinase; KLF-4: kruppel like factor 4; DKK1: dickkopf WNT signaling pathway inhibitor 1; ccRCC: clear cell renal cell carcinoma; PI3K: phosphoinositide 3-kinase; Ct: comparative threshold cycle; RPMI: Roswell Park Memorial Institute; FBS: fetal bovine serum; RT: reverse transcription; qPCR: quantitative polymerase chain reaction; RIPA: radioimmunoprecipitation assay; SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis; PVDF: polyvinylidene difluoride; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; MTT: 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; DMSO: dimethyl sulfoxide; DMEM: Dulbecco's modified Eagle's medium; PI: propidium iodide; SPF: specific pathogen-free; SD: standard deviation; p-Akt: phosphorylated-Akt; shRNAs: small hairpin RNAs; 3'UTR: 3'-untranslated regions.

Entities:  

Keywords:  Circular RNA; hepatocellular carcinoma; microRNA-7

Year:  2019        PMID: 31522588      PMCID: PMC6791692          DOI: 10.1080/15384101.2019.1664223

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  45 in total

1.  Upregulation of focal adhesion kinase by 14-3-3ε via NFκB activation in hepatocellular carcinoma.

Authors:  Bor-Sheng Ko; Yee-Jee Jan; Tzu-Ching Chang; Shu-Man Liang; Shyh-Chang Chen; Tzu-An Liu; Yao-Ming Wu; John Wang; Jun-Yang Liou
Journal:  Anticancer Agents Med Chem       Date:  2013-05       Impact factor: 2.505

2.  Global microarray profiling identified hsa_circ_0064428 as a potential immune-associated prognosis biomarker for hepatocellular carcinoma.

Authors:  Qiaoyou Weng; Minjiang Chen; Maoquan Li; Yong-Fa Zheng; Guoliang Shao; Weijun Fan; Xi-Ming Xu; Jiansong Ji
Journal:  J Med Genet       Date:  2018-08-17       Impact factor: 6.318

Review 3.  Gene signatures in hepatocellular carcinoma (HCC).

Authors:  Ourania M Andrisani; Leo Studach; Philippe Merle
Journal:  Semin Cancer Biol       Date:  2010-09-17       Impact factor: 15.707

Review 4.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

5.  An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.

Authors:  Chao Leng; Zhan-Guo Zhang; Wei-Xun Chen; Hong-Ping Luo; Jia Song; Wei Dong; Xuan-Ru Zhu; Xiao-Ping Chen; Hui-Fang Liang; Bi-Xiang Zhang
Journal:  Cancer Lett       Date:  2016-03-17       Impact factor: 8.679

6.  Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.

Authors:  Adriana Sergio; Chiara Cristofori; Romilda Cardin; Giorgio Pivetta; Roberto Ragazzi; Anna Baldan; Lisa Girardi; Umberto Cillo; Patrizia Burra; Anna Giacomin; Fabio Farinati
Journal:  Am J Gastroenterol       Date:  2008-01-02       Impact factor: 10.864

Review 7.  Circular RNA in Liver: Health and Diseases.

Authors:  Meiyi Song; Lu Xia; Mengxue Sun; Changqing Yang; Fei Wang
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

8.  Expression Profiling Identifies Circular RNA Signature in Hepatoblastoma.

Authors:  Bai-Hui Liu; Bin-Bin Zhang; Xiang-Qi Liu; Shan Zheng; Kui-Ran Dong; Rui Dong
Journal:  Cell Physiol Biochem       Date:  2018-01-31

9.  Circular RNA profiling identifies circADAMTS13 as a miR-484 sponge which suppresses cell proliferation in hepatocellular carcinoma.

Authors:  Liman Qiu; Yanbing Huang; Zhenli Li; Xiuqing Dong; Geng Chen; Haipo Xu; Yongyi Zeng; Zhixiong Cai; Xiaolong Liu; Jingfeng Liu
Journal:  Mol Oncol       Date:  2019-01-09       Impact factor: 6.603

Review 10.  Identifying and Characterizing circRNA-Protein Interaction.

Authors:  William W Du; Chao Zhang; Weining Yang; Tianqiao Yong; Faryal Mehwish Awan; Burton B Yang
Journal:  Theranostics       Date:  2017-09-26       Impact factor: 11.556

View more
  13 in total

Review 1.  The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers.

Authors:  Ying Shao; Bingjian Lu
Journal:  Cancer Metastasis Rev       Date:  2021-10-18       Impact factor: 9.264

2.  Circ_0015756 Aggravates Hepatocellular Carcinoma Development by Regulating FGFR1 via Sponging miR-610.

Authors:  Weisheng Guo; Lin Zhao; Guangya Wei; Peng Liu; Yu Zhang; Liran Fu
Journal:  Cancer Manag Res       Date:  2020-08-18       Impact factor: 3.989

3.  Circular RNA CircITCH (has-circ-0001141) suppresses hepatocellular carcinoma (HCC) progression by sponging miR-184.

Authors:  Xuan Guo; Ziying Wang; Xue Deng; Yantong Lu; Xuhui Huang; Juze Lin; Xiaohe Lan; Qiao Su; Changjun Wang
Journal:  Cell Cycle       Date:  2022-04-09       Impact factor: 5.173

Review 4.  Role of microRNA-7 in liver diseases: a comprehensive review of the mechanisms and therapeutic applications.

Authors:  Sen Han; Ting Zhang; Praveen Kusumanchi; Nazmul Huda; Yanchao Jiang; Suthat Liangpunsakul; Zhihong Yang
Journal:  J Investig Med       Date:  2020-08-24       Impact factor: 3.235

5.  Circular RNA hsa_circ_0000848 Promotes Trophoblast Cell Migration and Invasion and Inhibits Cell Apoptosis by Sponging hsa-miR-6768-5p.

Authors:  Hui Wang; Jianming Zhang; Zhiyong Xu; Jingxin Yang; Yong Xu; Yang Liu; Bohong Li; Jiansheng Xie; Jing Li
Journal:  Front Cell Dev Biol       Date:  2020-05-19

6.  Circ_0007444 Inhibits the Progression of Ovarian Cancer via Mediating the miR-570-3p/PTEN Axis.

Authors:  Xinyu Wu; Daoyan Liu; Shuzhen Wang; Jie Liu
Journal:  Onco Targets Ther       Date:  2021-01-07       Impact factor: 4.147

7.  Circ_0001175 Promotes Hepatocellular Carcinoma Cell Proliferation and Metastasis by Regulating miR-130a-5p.

Authors:  Liheng Li; Ke He; Siliang Chen; Wenjiang Wei; Zuofu Tian; Yinghong Tang; Chengjiang Xiao; Guoan Xiang
Journal:  Onco Targets Ther       Date:  2020-12-31       Impact factor: 4.147

Review 8.  Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma.

Authors:  Rui Liao; Lei Liu; Jian Zhou; Xufu Wei; Ping Huang
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

Review 9.  Diagnostic and prognostic value of circular RNAs in hepatocellular carcinoma.

Authors:  Jin-Yu Sun; Xiao-Yu Zhang; Yi-Zhi Cao; Xiao Zhou; Jian Gu; Xiao-Xin Mu
Journal:  J Cell Mol Med       Date:  2020-04-13       Impact factor: 5.310

Review 10.  Circular RNAs in gastrointestinal cancer: Current knowledge, biomarkers and targeted therapy (Review).

Authors:  Xiaorui Zhao; Yue Wang; Qiongfang Yu; Pei Yu; Qiaoyu Zheng; Xue Yang; Dian Gao
Journal:  Int J Mol Med       Date:  2020-09-16       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.